Maintenance Therapy: Clinical Trials

17 trials for Maintenance Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 3 completed, 3 unknown, 2 active not recruiting. 4 Not applicable, 4 Phase 4, 3 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4Unknown 3, Completed 1
Phase 44Completed 2, Not yet recruiting 1, Recruiting 1
Phase 23Recruiting 2, Not yet recruiting 1
Phase 33Recruiting 2, Active not recruiting 1
Phase 11Recruiting 1

Follow Maintenance Therapy: new trials by email Literature Review of Maintenance Therapy trials Research Report on Maintenance Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chidamide in HR-AML
Acute Myeloid Leukemia, Maintenance Therapy
Active not recruitingGuangdong Second Provincial General Hospital332026-07-272026-09-16
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Gilteritinib, Sorafenib - Acute Myeloid Leukemia (AML), FLT3-ITD Mutation
Phase 3RecruitingThe First Affiliated Hospital of Soochow University5942026-05-012026-03-20
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
Menin Inhibitors, Acute Leukemia
RecruitingThe First Affiliated Hospital of Soochow University202025-11-012026-04-30
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
BN104 monotherapy - Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation
Phase 2RecruitingThe First Affiliated Hospital of Soochow University602025-08-012025-08-03
Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
S-1 - Pancreatic Cancer, Postoperative Adjuvant Therapy
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University4642025-07-012025-04-03
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
Initial treatment: PD-1+ Oxaliplatin-based chemotherapy (CAPOX/SOX/FOLFOX), Maintenance treatment (after 3 months): fruquintinib+PD-1 - Gastric Adenocarcinoma, GEJ Adenocarcinoma
Phase 2Not yet recruitingRuijin Hospital552025-03-312025-03-21
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
Active Immunotherapy, after 6 courses of routine consolidation chemotherapy, during 6 courses of routine consolidation chemotherapy - Acute Myeloid Leukemia, Personalized Active Immunotherapy
Phase 1RecruitingFujian Medical University Union Hospital902024-09-012026-05-01
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
Zanubrutinib - Mantle Cell Lymphoma, Maintenance Therapy
Phase 2RecruitingFudan University522024-05-242024-09-04
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Maintenance Therapy with Toripalimab and Capecitabine, Maintenance Therapy with Capecitabine - Nasopharyngeal Carcinoma, High-Risk Cancer
Phase 3RecruitingJiangxi Provincial Cancer Hospital2642024-03-072026-05-15
Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
Capecitabine/Placebo combined with toripalimab - Nasopharyngeal Carcinoma, Maintenance Therapy
Phase 3Active not recruitingXIANG YANQUN1662023-04-282024-12-30
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Azathioprine, Telitacicept - ANCA-associated Vasculitis, Maintenance Therapy
Phase 4RecruitingChinese SLE Treatment And Research Group402023-03-092023-07-28
Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
Leflunomide, Azathioprine Tablets - ANCA Associated Vasculitis, Maintenance Therapy
Not applicableUnknownChinese SLE Treatment And Research Group1142021-06-302021-11-30
Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia
Build Stamina Program - Physical Activity, Exercise
Not applicableCompletedDuke University492021-01-152022-09-23
Nevirapine / Lamivudine for HIV Maintenance Therapy
Neviparine (NVP)/ Lamivudine (3TC) - HIV Infection, Antiretroviral Treatment
Phase 4CompletedCantonal Hospital of St. Gallen2012019-04-122025-06-10
Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo
Narrow-band UV-B therapy - Phototherapy, Vitiligo
Not applicableUnknownThe Catholic University of Korea1002017-11-182017-12-27
Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With Vitiligo
the 308-nm excimer laser - Vitiligo, Maintenance Therapy
Not applicableUnknownThe Catholic University of Korea1002017-11-182017-12-27
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)
Switch to DTG + FTC, Patient-centered monitoring - HIV-1-infection, Antiretroviral Therapy
Phase 4CompletedCalmy Alexandra1862017-05-192019-08-29

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Nasopharyngeal Carcinoma (2)  ·  Vitiligo (2)  ·  HIV Infections (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Motor Activity (1)  ·  Pancreatic Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Neoplasms (7)  ·  Neoplasms by Histologic Type (6)  ·  Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Hematologic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Myeloid (3)  ·  Neoplasms by Site (3)  ·  Autoimmune Diseases (2)  ·  Carcinoma (2)  ·  Cardiovascular Diseases (2)  ·  Head and Neck Neoplasms (2)  ·  Hypopigmentation (2)

Interventions

Azathioprine (2)  ·  Capecitabine (2)  ·  Maintenance (2)  ·  toripalimab (2)  ·  Immunotherapy, Active (1)  ·  Lamivudine (1)  ·  Lasers, Excimer (1)  ·  Leflunomide (1)  ·  Nevirapine (1)  ·  Racivir (1)  ·  S 1 (combination) (1)  ·  Sorafenib (1)  ·  gilteritinib (1)  ·  telitacicept (1)  ·  zanubrutinib (1)

Sponsors

The First Affiliated Hospital of Soochow University (3)  ·  Chinese SLE Treatment And Research Group (2)  ·  The Catholic University of Korea (2)  ·  Calmy Alexandra (1)  ·  Cantonal Hospital of St. Gallen (1)  ·  Duke University (1)  ·  Fudan University (1)  ·  Fujian Medical University Union Hospital (1)  ·  Guangdong Second Provincial General Hospital (1)  ·  Jiangxi Provincial Cancer Hospital (1)  ·  Ruijin Hospital (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  XIANG YANQUN (1)

Countries

China (12)  ·  South Korea (2)  ·  Switzerland (2)  ·  United States (1)

Top investigators

Su-ning Chen, M.D. (2)  ·  JIng Li, M.D. (1)  ·  Jingao Li (1)  ·  Meijuan Huang (1)  ·  Pietro Vernazza, Professor (1)  ·  Tara A Albrecht, PhD, ACNP-BC, ACNP-BC, ACHPN (1)  ·  Xinping Tian (1)  ·  Yizhen Liu, M.D., Ph.D. (1)

Results publications

PMID 33170863, PMID 38754068